BR100 Increased By (0.12%)
BR30 Increased By (0.53%)
KSE100 Increased By (0.32%)
KSE30 Increased By (0.42%)
AGHA 6.41 Increased By ▲ 0.09 (1.42%)
BECO 4.37 Increased By ▲ 0.10 (2.34%)
BML 63.00 Increased By ▲ 0.55 (0.88%)
BOP 31.50 Increased By ▲ 0.27 (0.86%)
CNERGY 11.69 Increased By ▲ 0.10 (0.86%)
CSIL 5.89 Increased By ▲ 0.17 (2.97%)
FCCL 60.84 Decreased By ▼ -0.70 (-1.14%)
FFL 14.72 Decreased By ▼ -0.30 (-2%)
FNEL 1.23 No Change ▼ 0.00 (0%)
KEL 6.33 Increased By ▲ 0.07 (1.12%)
KOSM 5.94 Increased By ▲ 0.38 (6.83%)
LOTCHEM 24.68 No Change ▼ 0.00 (0%)
MLCF 103.25 Decreased By ▼ -0.83 (-0.8%)
NBP 173.10 Decreased By ▼ -2.18 (-1.24%)
NCPL 52.25 Decreased By ▼ -0.52 (-0.99%)
NPL 54.10 Decreased By ▼ -0.02 (-0.04%)
OGDC 316.78 Increased By ▲ 3.39 (1.08%)
PACE 9.20 No Change ▼ 0.00 (0%)
PAEL 35.80 No Change ▼ 0.00 (0%)
PIBTL 13.62 Increased By ▲ 0.15 (1.11%)
PPL 226.60 Increased By ▲ 4.79 (2.16%)
PRL 80.50 Increased By ▲ 1.42 (1.8%)
PTC 46.99 Increased By ▲ 0.14 (0.3%)
SSGC 23.70 Decreased By ▼ -0.17 (-0.71%)
TBL 9.29 Decreased By ▼ -0.02 (-0.21%)
TELE 7.54 Increased By ▲ 0.15 (2.03%)
TPL 24.69 Decreased By ▼ -0.42 (-1.67%)
TPLP 12.87 Increased By ▲ 0.36 (2.88%)
TREET 26.35 Increased By ▲ 0.10 (0.38%)
TRG 53.38 Decreased By ▼ -0.06 (-0.11%)
World

Canada regulator expects to complete Moderna COVID-19 vaccine approval in coming weeks

  • Health Canada said it cannot provide a definite timeline for the vaccine approval but expects the process to be completed in the coming weeks.
Published Updated
By

Canadian health regulator said it expects to complete the review on Moderna Inc's coronavirus vaccine in the coming weeks after the U.S. Food and Drug Administration approved its emergency use on Friday.

"There is still information and data to be provided by Moderna for review," the regulator said in a statement.

Health Canada said it cannot provide a definite timeline for the vaccine approval but expects the process to be completed in the coming weeks.

Canada on Tuesday also announced an agreement to receive early deliveries of the Moderna vaccine amid a surge of new cases that are forcing new health restrictions across the country.

Moderna had begun the rolling submission of its vaccine candidate in Canada in October following positive early results from studies.

Last week Canada's health ministry had approved Pfizer Inc's vaccine, developed with Germany's BioNTech SE .

It has also received applications for other experimental vaccines from AstraZeneca Plc and Johnson & Johnson.

Comments

Comments are closed for this article.